4-[(S)-1-((2S,4bS,7S,8aR)-7-Hydroxy-2,4b-dimethyl-tetradecahydro-phenanthren-2-yl)-propyl]-5H-furan-2-one

ID: ALA318786

PubChem CID: 44334319

Max Phase: Preclinical

Molecular Formula: C23H36O3

Molecular Weight: 360.54

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CC[C@H](C1=CC(=O)OC1)[C@@]1(C)CCC2C(CC[C@@H]3C[C@@H](O)CC[C@]23C)C1

Standard InChI:  InChI=1S/C23H36O3/c1-4-19(16-11-21(25)26-14-16)22(2)9-8-20-15(13-22)5-6-17-12-18(24)7-10-23(17,20)3/h11,15,17-20,24H,4-10,12-14H2,1-3H3/t15?,17-,18+,19-,20?,22+,23+/m1/s1

Standard InChI Key:  UMJZDACYLLYXCX-DAGMFSKESA-N

Molfile:  

     RDKit          2D

 28 31  0  0  1  0  0  0  0  0999 V2000
   -2.8500    1.1375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2250    2.6000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2875    2.0333    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3333    1.4375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4250    3.1708    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8500    0.5375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8125    1.1375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0500    3.5250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2958    1.4333    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7125    2.2125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5417    3.1875    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3750    1.4375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3333    2.0375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3750    2.6125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8083    2.3375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3750    0.2375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3375    0.2375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8208    0.5375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0375    4.1250    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8958    1.1375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8958    0.5375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8583    1.7375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2875    2.6333    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4083    0.2458    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3625    1.7250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2292    1.7833    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1250    2.1583    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7000   -0.2000    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
 10  2  1  1
  3 15  1  0
  4  1  1  0
  5  2  2  0
  6  1  1  0
  7  4  1  0
  8  5  1  0
  9  7  1  0
 10  3  1  0
 11 14  1  0
 12  1  1  0
 13  4  1  0
 14  2  1  0
 15 13  1  0
 16  6  1  0
 17  6  1  0
 18 17  1  0
 19  8  2  0
 20 12  1  0
 21 20  1  0
  1 22  1  1
  3 23  1  1
 21 24  1  1
 25 10  1  0
 26 25  1  0
 10 27  1  6
  6 28  1  1
 21 16  1  0
  7 18  1  0
  9  3  1  0
  8 11  1  0
M  END

Associated Targets(Human)

ATP12A Tchem Potassium-transporting ATPase alpha chain 2 (83 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 360.54Molecular Weight (Monoisotopic): 360.2664AlogP: 4.88#Rotatable Bonds: 3
Polar Surface Area: 46.53Molecular Species: NEUTRALHBA: 3HBD: 1
#RO5 Violations: HBA (Lipinski): 3HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 7.22CX Basic pKa: CX LogP: 4.77CX LogD: 4.37
Aromatic Rings: Heavy Atoms: 26QED Weighted: 0.73Np Likeness Score: 2.57

References

1. De Munari S, Barassi P, Cerri A, Fedrizzi G, Gobbini M, Mabilia M, Melloni P..  (1998)  A new approach to the design of novel inhibitors of Na+,K+-ATPase: 17alpha-substituted seco-D 5beta-androstane as cassaine analogues.,  41  (16): [PMID:9685243] [10.1021/jm980108d]

Source